Global Neuromodulation Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Neuromodulation market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Neuromodulation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Neuromodulation market by type, application, key companies and key regions.
This study considers the Neuromodulation value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Internal Treatment
External Treatment
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Ischemia
Chronic Pain
Parkinson's
Depression
Tremor
Epilepsy
Migraine
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Medtronic
BioControl Medical
Boston Scientific Corporation
LivaNova
Synapse Biomedical, Inc.
Abbott
NeuroPace
Nevro Corporation
Neuronetics
NeuroSigma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Neuromodulation market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Neuromodulation market by identifying its various subsegments.
Focuses on the key global Neuromodulation players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neuromodulation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Neuromodulation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuromodulation Market Size 2015-2025
2.1.2 Neuromodulation Market Size CAGR by Region
2.2 Neuromodulation Segment by Type
2.2.1 Internal Treatment
2.2.2 Internal Treatment
2.3 Neuromodulation Market Size by Type
2.3.1 Global Neuromodulation Market Size Market Share by Type (2015-2020)
2.3.2 Global Neuromodulation Market Size Growth Rate by Type (2015-2020)
2.4 Neuromodulation Segment by Application
2.4.1 Ischemia
2.4.2 Chronic Pain
2.4.3 Parkinson's
2.4.4 Depression
2.4.5 Tremor
2.4.6 Epilepsy
2.4.7 Migraine
2.5 Neuromodulation Market Size by Application
2.5.1 Global Neuromodulation Market Size Market Share by Application (2015-2020)
2.5.2 Global Neuromodulation Market Size Growth Rate by Application (2015-2020)
3 Global Neuromodulation by Players
3.1 Global Neuromodulation Market Size Market Share by Players
3.1.1 Global Neuromodulation Market Size by Players (2018-2020)
3.1.2 Global Neuromodulation Market Size Market Share by Players (2018-2020)
3.2 Global Neuromodulation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neuromodulation by Regions
4.1 Neuromodulation Market Size by Regions
4.2 Americas Neuromodulation Market Size Growth
4.3 APAC Neuromodulation Market Size Growth
4.4 Europe Neuromodulation Market Size Growth
4.5 Middle East & Africa Neuromodulation Market Size Growth
5 Americas
5.1 Americas Neuromodulation Market Size by Countries
5.2 Americas Neuromodulation Market Size by Type
5.3 Americas Neuromodulation Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neuromodulation Market Size by Regions
6.2 APAC Neuromodulation Market Size by Type
6.3 APAC Neuromodulation Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Neuromodulation by Countries
7.2 Europe Neuromodulation Market Size by Type
7.3 Europe Neuromodulation Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neuromodulation by Countries
8.2 Middle East & Africa Neuromodulation Market Size by Type
8.3 Middle East & Africa Neuromodulation Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Neuromodulation Market Forecast
10.1 Global Neuromodulation Market Size Forecast (2021-2025)
10.2 Global Neuromodulation Forecast by Regions
10.2.1 Global Neuromodulation Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Neuromodulation Forecast by Type
10.8 Global Neuromodulation Forecast by Application
11 Key Players Analysis
11.1 Medtronic
11.1.1 Company Details
11.1.2 Neuromodulation Product Offered
11.1.3 Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Medtronic News
11.2 BioControl Medical
11.2.1 Company Details
11.2.2 Neuromodulation Product Offered
11.2.3 BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 BioControl Medical News
11.3 Boston Scientific Corporation
11.3.1 Company Details
11.3.2 Neuromodulation Product Offered
11.3.3 Boston Scientific Corporation Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Boston Scientific Corporation News
11.4 LivaNova
11.4.1 Company Details
11.4.2 Neuromodulation Product Offered
11.4.3 LivaNova Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 LivaNova News
11.5 Synapse Biomedical, Inc.
11.5.1 Company Details
11.5.2 Neuromodulation Product Offered
11.5.3 Synapse Biomedical, Inc. Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Synapse Biomedical, Inc. News
11.6 Abbott
11.6.1 Company Details
11.6.2 Neuromodulation Product Offered
11.6.3 Abbott Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Abbott News
11.7 NeuroPace
11.7.1 Company Details
11.7.2 Neuromodulation Product Offered
11.7.3 NeuroPace Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 NeuroPace News
11.8 Nevro Corporation
11.8.1 Company Details
11.8.2 Neuromodulation Product Offered
11.8.3 Nevro Corporation Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Nevro Corporation News
11.9 Neuronetics
11.9.1 Company Details
11.9.2 Neuromodulation Product Offered
11.9.3 Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Neuronetics News
11.10 NeuroSigma
11.10.1 Company Details
11.10.2 Neuromodulation Product Offered
11.10.3 NeuroSigma Neuromodulation Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 NeuroSigma News
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Neuromodulation Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Internal Treatment
Table 5. Major Players of External Treatment
Table 6. Neuromodulation Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Neuromodulation Market Size Market Share by Type (2015-2020)
Table 8. Global Neuromodulation Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Neuromodulation Market Size Market Share by Application (2015-2020)
Table 10. Global Neuromodulation Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Neuromodulation Revenue Market Share by Players (2018-2020)
Table 12. Global Neuromodulation Key Players Head office and Products Offered
Table 13. Neuromodulation Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Neuromodulation Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Neuromodulation Market Size Market Share by Regions 2015-2020
Table 18. Americas Neuromodulation Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Neuromodulation Market Size Market Share by Countries (2015-2020)
Table 20. Americas Neuromodulation Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Neuromodulation Market Size Market Share by Type (2015-2020)
Table 22. Americas Neuromodulation Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Neuromodulation Market Size Market Share by Application (2015-2020)
Table 24. APAC Neuromodulation Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Neuromodulation Market Size Market Share by Regions (2015-2020)
Table 26. APAC Neuromodulation Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Neuromodulation Market Size Market Share by Type (2015-2020)
Table 28. APAC Neuromodulation Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Neuromodulation Market Size Market Share by Application (2015-2020)
Table 30. Europe Neuromodulation Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Neuromodulation Market Size Market Share by Countries (2015-2020)
Table 32. Europe Neuromodulation Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Neuromodulation Market Size Market Share by Type (2015-2020)
Table 34. Europe Neuromodulation Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Neuromodulation Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Neuromodulation Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Neuromodulation Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Neuromodulation Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Neuromodulation Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Neuromodulation Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Neuromodulation Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Neuromodulation
Table 43. Key Application and Potential Industries of Neuromodulation
Table 44. Key Challenges of Neuromodulation
Table 45. Key Trends of Neuromodulation
Table 46. Global Neuromodulation Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Neuromodulation Market Size Market Share Forecast by Regions
Table 48. Global Neuromodulation Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Neuromodulation Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Neuromodulation Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Neuromodulation Market Size Market Share Forecast by Application (2021-2025)
Table 52. Medtronic Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 53. Medtronic Neuromodulation Product Offered
Table 54. Medtronic Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 55. Medtronic Main Business
Table 56. Medtronic Latest Developments
Table 57. BioControl Medical Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 58. BioControl Medical Neuromodulation Product Offered
Table 59. BioControl Medical Main Business
Table 60. BioControl Medical Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 61. BioControl Medical Latest Developments
Table 62. Boston Scientific Corporation Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 63. Boston Scientific Corporation Neuromodulation Product Offered
Table 64. Boston Scientific Corporation Main Business
Table 65. Boston Scientific Corporation Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 66. Boston Scientific Corporation Latest Developments
Table 67. LivaNova Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 68. LivaNova Neuromodulation Product Offered
Table 69. LivaNova Main Business
Table 70. LivaNova Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 71. LivaNova Latest Developments
Table 72. Synapse Biomedical, Inc. Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 73. Synapse Biomedical, Inc. Neuromodulation Product Offered
Table 74. Synapse Biomedical, Inc. Main Business
Table 75. Synapse Biomedical, Inc. Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 76. Synapse Biomedical, Inc. Latest Developments
Table 77. Abbott Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 78. Abbott Neuromodulation Product Offered
Table 79. Abbott Main Business
Table 80. Abbott Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 81. Abbott Latest Developments
Table 82. NeuroPace Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 83. NeuroPace Neuromodulation Product Offered
Table 84. NeuroPace Main Business
Table 85. NeuroPace Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 86. NeuroPace Latest Developments
Table 87. Nevro Corporation Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 88. Nevro Corporation Neuromodulation Product Offered
Table 89. Nevro Corporation Main Business
Table 90. Nevro Corporation Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 91. Nevro Corporation Latest Developments
Table 92. Neuronetics Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 93. Neuronetics Neuromodulation Product Offered
Table 94. Neuronetics Main Business
Table 95. Neuronetics Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 96. Neuronetics Latest Developments
Table 97. NeuroSigma Details, Company Total Revenue (in $ million), Head Office, Neuromodulation Major Market Areas and Its Competitors
Table 98. NeuroSigma Neuromodulation Product Offered
Table 99. NeuroSigma Main Business
Table 100. NeuroSigma Neuromodulation Revenue and Gross Margin (2018-2020E)
Table 101. NeuroSigma Latest Developments
List of Figures
Figure 1. Neuromodulation Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Neuromodulation Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Neuromodulation Market Size Market Share by Type (2015-2020)
Figure 5. Global Internal Treatment Market Size Growth Rate
Figure 6. Global External Treatment Market Size Growth Rate
Figure 7. Neuromodulation in Ischemia
Figure 8. Global Neuromodulation Market: Ischemia (2015-2020) ($ Millions)
Figure 9. Neuromodulation in Chronic Pain
Figure 10. Global Neuromodulation Market: Chronic Pain (2015-2020) ($ Millions)
Figure 11. Neuromodulation in Parkinson's
Figure 12. Global Neuromodulation Market: Parkinson's (2015-2020) ($ Millions)
Figure 13. Global Parkinson's YoY Growth ($ Millions)
Figure 14. Neuromodulation in Depression
Figure 15. Global Neuromodulation Market: Depression (2015-2020) ($ Millions)
Figure 16. Global Depression YoY Growth ($ Millions)
Figure 17. Neuromodulation in Tremor
Figure 18. Global Neuromodulation Market: Tremor (2015-2020) ($ Millions)
Figure 19. Global Tremor YoY Growth ($ Millions)
Figure 20. Global Neuromodulation Market Size Market Share by Application in 2019
Figure 21. Global Neuromodulation Market Size Market Share by Regions 2015-2020
Figure 22. Americas Neuromodulation Market Size 2015-2020 ($ Millions)
Figure 23. APAC Neuromodulation Market Size 2015-2020 ($ Millions)
Figure 24. Europe Neuromodulation Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Neuromodulation Market Size 2015-2020 ($ Millions)
Figure 26. Americas Neuromodulation Market Size Market Share by Countries in 2019
Figure 27. Americas Neuromodulation Market Size Market Share by Type in 2019
Figure 28. Americas Neuromodulation Market Size Market Share by Application in 2019
Figure 29. United States Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Neuromodulation Market Size Market Share by Regions in 2019
Figure 33. APAC Neuromodulation Market Size Market Share by Type in 2019
Figure 34. APAC Neuromodulation Market Size Market Share by Application in 2019
Figure 35. China Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Neuromodulation Market Size Market Share by Countries in 2019
Figure 42. Europe Neuromodulation Market Size Market Share by Type in 2019
Figure 43. Europe Neuromodulation Market Size Market Share by Application in 2019
Figure 44. Germany Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Neuromodulation Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Neuromodulation Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Neuromodulation Market Size Market Share by Application in 2019
Figure 53. Egypt Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Neuromodulation Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Neuromodulation arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 60. APAC Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 61. Europe Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 63. United States Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 64. Canada Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 67. China Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 68. Japan Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 69. Korea Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 71. India Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 72. Australia Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 73. Germany Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 74. France Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 75. UK Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 76. Italy Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 77. Russia Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 78. Spain Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 81. Israel Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Neuromodulation Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Neuromodulation Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets